Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Shenfeng Pharmaceutical is a Chinese biotechnology company specializing in the development and manufacture of biological products, most notably vaccines. The company is widely recognized for its Purified Rabies Vaccine for Human Use (Vero Cell), which is a core product in its portfolio. Based in Dalian, Liaoning Province, it operates large-scale GMP-certified manufacturing facilities to support domestic and international supply. Beyond vaccines, the company focuses on the research and production of recombinant protein drugs and other biological therapeutics such as erythropoietin and interferon. Dalian Shenfeng plays a significant role in China's biopharmaceutical infrastructure, contributing to public health through the prevention of infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian ShenFeng Pharmaceutical.